CN106728672A - A kind for the treatment of and the pharmaceutical formulation of preventing hypertension - Google Patents

A kind for the treatment of and the pharmaceutical formulation of preventing hypertension Download PDF

Info

Publication number
CN106728672A
CN106728672A CN201611175978.7A CN201611175978A CN106728672A CN 106728672 A CN106728672 A CN 106728672A CN 201611175978 A CN201611175978 A CN 201611175978A CN 106728672 A CN106728672 A CN 106728672A
Authority
CN
China
Prior art keywords
parts
fruit
radix
treatment
pharmaceutical formulation
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN201611175978.7A
Other languages
Chinese (zh)
Inventor
刘兴成
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Priority to CN201611175978.7A priority Critical patent/CN106728672A/en
Publication of CN106728672A publication Critical patent/CN106728672A/en
Pending legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/32—Bones; Osteocytes; Osteoblasts; Tendons; Tenocytes; Teeth; Odontoblasts; Cartilage; Chondrocytes; Synovial membrane
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/56—Materials from animals other than mammals
    • A61K35/618—Molluscs, e.g. fresh-water molluscs, oysters, clams, squids, octopus, cuttlefish, snails or slugs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/56—Materials from animals other than mammals
    • A61K35/62—Leeches; Worms, e.g. cestodes, tapeworms, nematodes, roundworms, earth worms, ascarids, filarias, hookworms, trichinella or taenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/06—Fungi, e.g. yeasts
    • A61K36/07—Basidiomycota, e.g. Cryptococcus
    • A61K36/076—Poria
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/21—Amaranthaceae (Amaranth family), e.g. pigweed, rockwort or globe amaranth
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/23—Apiaceae or Umbelliferae (Carrot family), e.g. dill, chervil, coriander or cumin
    • A61K36/232—Angelica
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/25—Araliaceae (Ginseng family), e.g. ivy, aralia, schefflera or tetrapanax
    • A61K36/258—Panax (ginseng)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/28—Asteraceae or Compositae (Aster or Sunflower family), e.g. chamomile, feverfew, yarrow or echinacea
    • A61K36/287—Chrysanthemum, e.g. daisy
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/42—Cucurbitaceae (Cucumber family)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
    • A61K36/481—Astragalus (milkvetch)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/53—Lamiaceae or Labiatae (Mint family), e.g. thyme, rosemary or lavender
    • A61K36/537—Salvia (sage)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/57—Magnoliaceae (Magnolia family)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/63—Oleaceae (Olive family), e.g. jasmine, lilac or ash tree
    • A61K36/638—Ligustrum, e.g. Chinese privet
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/70—Polygonaceae (Buckwheat family), e.g. spineflower or dock
    • A61K36/704—Polygonum, e.g. knotweed
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/74—Rubiaceae (Madder family)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/79—Schisandraceae (Schisandra family)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/80—Scrophulariaceae (Figwort family)
    • A61K36/804—Rehmannia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/88—Liliopsida (monocotyledons)
    • A61K36/888—Araceae (Arum family), e.g. caladium, calla lily or skunk cabbage
    • A61K36/8884—Arisaema, e.g. Jack in the pulpit
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/88—Liliopsida (monocotyledons)
    • A61K36/894—Dioscoreaceae (Yam family)
    • A61K36/8945—Dioscorea, e.g. yam, Chinese yam or water yam

Landscapes

  • Health & Medical Sciences (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Biotechnology (AREA)
  • Mycology (AREA)
  • Engineering & Computer Science (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Botany (AREA)
  • Medical Informatics (AREA)
  • Microbiology (AREA)
  • Zoology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Marine Sciences & Fisheries (AREA)
  • Rheumatology (AREA)
  • Biomedical Technology (AREA)
  • Cell Biology (AREA)
  • Developmental Biology & Embryology (AREA)
  • Immunology (AREA)
  • Virology (AREA)
  • Medicines Containing Plant Substances (AREA)

Abstract

The invention discloses a kind for the treatment of and the pharmaceutical formulation of preventing hypertension, it is made up of according to weight portion following medicine：6 parts of antelope's horn, 65 parts of the shell of seaear, 25 parts of the Radix Astragali, 15 parts of luffa, 20 parts of the red sage root, 10 parts of the fruit of Chinese magnoliavine, 10 parts of pseudo-ginseng, 20 parts of Chinese yam, 20 parts of Poria cocos, 15 parts of the fleece-flower root, 15 parts of Radix Angelicae Sinensis, 50 parts of yncaria stem with hooks, 35 parts of chrysanthemum, 50 parts of glutinous rehmannia, 50 parts of the fruit of glossy privet, 65 parts of earthworm, 65 parts of radix cyathulae, 35 parts of rhizoma arisaematis, 5 parts of menthol.Chinese medicine preparation of the invention rationally, improves each function after cooperation, promote QI-blood circulation, makes internal equilibrium between yin and yang, help this it is solid just phlegm is turbid to be difficult to gather, reach stagnation resolvation eliminating phlegm, eliminate the effect of numbness resistance；Medicine of the invention can be from basic thoroughly treatment essential hypertension, and rapid-action, effect is good, and recurrence is difficult after treatment；Older, fat is the people at highest risk of hypertension, and medicine of the invention can also do prevention for people at highest risk and be used.

Description

A kind for the treatment of and the pharmaceutical formulation of preventing hypertension
Technical field
The present invention relates to the field of Chinese medicines, the pharmaceutical formulation of specifically a kind for the treatment of and preventing hypertension.
Background technology
The incidence of disease more and more higher of hypertension over year, the increasingly younger trend of age of onset.It is general that the disease is treated at present Based on Western medicine depressor, conventional western medicine of depressurization includes the type such as diuresis, the slow heart, calmness, expansion of blood vessels.Diuresis class is depressured Medicine, long-term taking can cause body fluid metabolic dysfunction, be easily caused diabetes, kidney failure；The slow heart, calm hypotensor, it is long Phase takes and can make that human action is too slow, and brain response is blunt, is easily caused heart failure, depression；Expansion of blood vessels class is depressured Medicine, long-term taking can make one blood vessel and gradually follow the string and harden, and cause cardiovascular and cerebrovascular artery and renal arteriosclerosis, blood on surface Pressure drop, but substantially artery sclerosis increasingly aggravate, the harm of headstroke, coronary heart disease and kidney failure can be so aggravated on the contrary Property.Here it is why many long-term patients for taking hypertension pill, can be in the case of pressure value be very normal, burst cerebral hemorrhage, brain Infraction and miocardial infarction and lethal main cause.
These situations show that the Western medicine toxic and side effect of existing treatment hypertension is big, disturbs the physiological function of each system of whole body, Therefore hypertension treatment should with curative effect high, low side effect as standard, not with damage organ function and accelerate aging be cost, To start with from enhancing vis medicatrix naturae.
The content of the invention
It is an object of the invention to provide a kind for the treatment of and the pharmaceutical formulation of preventing hypertension, to solve above-mentioned background technology The problem of middle proposition.
To achieve the above object, the present invention provides following technical scheme：
A kind for the treatment of and the pharmaceutical formulation of preventing hypertension, are made up of following medicine according to weight portion：Antelope's horn 2-10 parts, Shell of seaear 50-80 parts, Radix Astragali 20-30 parts, luffa 10-20 parts, red sage root 15-25 parts, fruit of Chinese magnoliavine 5-15 parts, pseudo-ginseng 5-15 parts, Chinese yam 15-25 parts, Poria cocos 15-25 parts, fleece-flower root 10-20 parts, Radix Angelicae Sinensis 10-20 parts, yncaria stem with hooks 30-70 parts, chrysanthemum 20-50 parts, It is yellow 30-70 parts, fruit of glossy privet 30-70 parts, earthworm 50-80 parts, radix cyathulae 50-80 parts, rhizoma arisaematis 20-50 parts, menthol 2-8 parts.
As further scheme of the invention：It is made up of according to weight portion following medicine：Antelope's horn 4-8 parts, shell of seaear 55- 75 parts, Radix Astragali 22-28 parts, luffa 12-18 parts, red sage root 17-23 parts, fruit of Chinese magnoliavine 7-13 parts, pseudo-ginseng 7-13 parts, Chinese yam 17-23 Part, Poria cocos 17-23 parts, fleece-flower root 12-18 parts, Radix Angelicae Sinensis 12-18 parts, yncaria stem with hooks 40-60 parts, chrysanthemum 25-45 parts, glutinous rehmannia 40-60 parts, Fruit of glossy privet 40-60 parts, earthworm 55-75 parts, radix cyathulae 55-75 parts, rhizoma arisaematis 25-45 parts, menthol 4-6 parts.
As further scheme of the invention：It is made up of according to weight portion following medicine：6 parts of antelope's horn, 65 parts of the shell of seaear, 25 parts of the Radix Astragali, 15 parts of luffa, 20 parts of the red sage root, 10 parts of the fruit of Chinese magnoliavine, 10 parts of pseudo-ginseng, 20 parts of Chinese yam, 20 parts of Poria cocos, the fleece-flower root 15 Part, 15 parts of Radix Angelicae Sinensis, 50 parts of yncaria stem with hooks, 35 parts of chrysanthemum, 50 parts of glutinous rehmannia, 50 parts of the fruit of glossy privet, 65 parts of earthworm, 65 parts of radix cyathulae, rhizoma arisaematis 35 parts, 5 parts of menthol.
As further scheme of the invention：It is made up of according to weight portion following medicine：10 parts of antelope's horn, the shell of seaear 80 Part, 30 parts of the Radix Astragali, 20 parts of luffa, 25 parts of the red sage root, 15 parts of the fruit of Chinese magnoliavine, 15 parts of pseudo-ginseng, 25 parts of Chinese yam, 25 parts of Poria cocos, the fleece-flower root 20 parts, 20 parts of Radix Angelicae Sinensis, 70 parts of yncaria stem with hooks, 50 parts of chrysanthemum, 70 parts of glutinous rehmannia, 70 parts of the fruit of glossy privet, 80 parts of earthworm, radix cyathulae 80 part, day south 50 parts of star, 8 parts of menthol.
As further scheme of the invention：It is made up of according to weight portion following medicine：2 parts of antelope's horn, 50 parts of the shell of seaear, 20 parts of the Radix Astragali, 10 parts of luffa, 15 parts of the red sage root, 5 parts of the fruit of Chinese magnoliavine, 5 parts of pseudo-ginseng, 15 parts of Chinese yam, 15 parts of Poria cocos, 10 parts of the fleece-flower root, 10 parts of Radix Angelicae Sinensis, 30 parts of yncaria stem with hooks, 20 parts of chrysanthemum, 30 parts of glutinous rehmannia, 30 parts of the fruit of glossy privet, 50 parts of earthworm, 50 parts of radix cyathulae, rhizoma arisaematis 20 Part, 2 parts of menthol.
Compared with prior art, Chinese medicine preparation of the invention rationally, improves each function after cooperation, promotes qi and blood fortune OK, make internal equilibrium between yin and yang, help sheet to consolidate just, phlegm is turbid to be difficult to gather, and reaches stagnation resolvation eliminating phlegm, eliminates the effect of numbness resistance；It is of the invention Medicine can be from basic thoroughly treatment essential hypertension, and rapid-action, effect is good, and recurrence is difficult after treatment；Older, fat is high The people at highest risk of blood pressure, medicine of the invention can also do prevention for people at highest risk and be used.
Specific embodiment
The technical scheme of this patent is described in more detail with reference to specific embodiment.
Embodiment 1
A kind for the treatment of and the pharmaceutical formulation of preventing hypertension, are made up of following medicine according to weight portion：6 parts of antelope's horn, stone 65 parts of Cassia, 25 parts of the Radix Astragali, 15 parts of luffa, 20 parts of the red sage root, 10 parts of the fruit of Chinese magnoliavine, 10 parts of pseudo-ginseng, 20 parts of Chinese yam, 20 parts of Poria cocos, 15 parts of the fleece-flower root, 15 parts of Radix Angelicae Sinensis, 50 parts of yncaria stem with hooks, 35 parts of chrysanthemum, 50 parts of glutinous rehmannia, 50 parts of the fruit of glossy privet, 65 parts of earthworm, radix cyathulae 65 Part, 35 parts of rhizoma arisaematis, 5 parts of menthol.
Embodiment 2
A kind for the treatment of and the pharmaceutical formulation of preventing hypertension, are made up of following medicine according to weight portion：10 parts of antelope's horn, stone 80 parts of Cassia, 30 parts of the Radix Astragali, 20 parts of luffa, 25 parts of the red sage root, 15 parts of the fruit of Chinese magnoliavine, 15 parts of pseudo-ginseng, 25 parts of Chinese yam, 25 parts of Poria cocos, 20 parts of the fleece-flower root, 20 parts of Radix Angelicae Sinensis, 70 parts of yncaria stem with hooks, 50 parts of chrysanthemum, 70 parts of glutinous rehmannia, 70 parts of the fruit of glossy privet, 80 parts of earthworm, radix cyathulae 80 Part, 50 parts of rhizoma arisaematis, 8 parts of menthol.
Embodiment 3
A kind for the treatment of and the pharmaceutical formulation of preventing hypertension, are made up of following medicine according to weight portion：2 parts of antelope's horn, stone 50 parts of Cassia, 20 parts of the Radix Astragali, 10 parts of luffa, 15 parts of the red sage root, 5 parts of the fruit of Chinese magnoliavine, 5 parts of pseudo-ginseng, 15 parts of Chinese yam, 15 parts of Poria cocos, what 10 parts of the tuber of multiflower knotweed, 10 parts of Radix Angelicae Sinensis, 30 parts of yncaria stem with hooks, 20 parts of chrysanthemum, 30 parts of glutinous rehmannia, 30 parts of the fruit of glossy privet, 50 parts of earthworm, 50 parts of radix cyathulae, 20 parts of rhizoma arisaematis, 2 parts of menthol.
Chinese medicine preparation of the invention rationally, improves each function after cooperation, promote QI-blood circulation, equals internal negative and positive Weighing apparatus, helps this solid just, and phlegm is turbid to be difficult to gather, and reaches stagnation resolvation eliminating phlegm, eliminates the effect of numbness resistance；Medicine of the invention can from it is basic thoroughly Treatment essential hypertension, rapid-action, effect is good, and recurrence is difficult after treatment；Older, fat is the people at highest risk of hypertension, Medicine of the invention can also do prevention for people at highest risk and be used.
The better embodiment to this patent is explained in detail above, but this patent is not limited to above-mentioned embodiment party Formula, in the ken that one skilled in the relevant art possesses, can also be on the premise of this patent objective not be departed from Make a variety of changes.

Claims (5)

1. it is a kind of treat and preventing hypertension pharmaceutical formulation, it is characterised in that be made up of according to weight portion following medicine：Antelope Angle 2-10 parts, shell of seaear 50-80 parts, Radix Astragali 20-30 parts, luffa 10-20 parts, red sage root 15-25 parts, fruit of Chinese magnoliavine 5-15 parts, three Seven 5-15 parts, Chinese yam 15-25 parts, Poria cocos 15-25 parts, fleece-flower root 10-20 parts, Radix Angelicae Sinensis 10-20 parts, yncaria stem with hooks 30-70 parts, chrysanthemum 20-50 parts, glutinous rehmannia 30-70 parts, fruit of glossy privet 30-70 parts, earthworm 50-80 parts, radix cyathulae 50-80 parts, rhizoma arisaematis 20-50 parts, it is thin 2-8 parts of lotus brain.
2. it is according to claim 1 treatment and preventing hypertension pharmaceutical formulation, it is characterised in that by following medicine according to Weight portion is constituted：Antelope's horn 4-8 parts, shell of seaear 55-75 parts, Radix Astragali 22-28 parts, luffa 12-18 parts, red sage root 17-23 parts, five Taste 7-13 parts, pseudo-ginseng 7-13 parts, Chinese yam 17-23 parts, Poria cocos 17-23 parts, fleece-flower root 12-18 parts, Radix Angelicae Sinensis 12-18 parts, yncaria stem with hooks 40-60 parts, chrysanthemum 25-45 parts, glutinous rehmannia 40-60 parts, fruit of glossy privet 40-60 parts, earthworm 55-75 parts, radix cyathulae 55-75 parts, day south Star 25-45 parts, menthol 4-6 parts.
3. it is according to claim 1 and 2 treatment and preventing hypertension pharmaceutical formulation, it is characterised in that by following medicine Constituted according to weight portion：6 parts of antelope's horn, 65 parts of the shell of seaear, 25 parts of the Radix Astragali, 15 parts of luffa, 20 parts of the red sage root, 10 parts of the fruit of Chinese magnoliavine, 10 parts of pseudo-ginseng, 20 parts of Chinese yam, 20 parts of Poria cocos, 15 parts of the fleece-flower root, 15 parts of Radix Angelicae Sinensis, 50 parts of yncaria stem with hooks, 35 parts of chrysanthemum, 50 parts of glutinous rehmannia, female Loyal 50 parts of son, 65 parts of earthworm, 65 parts of radix cyathulae, 35 parts of rhizoma arisaematis, 5 parts of menthol.
4. it is according to claim 1 treatment and preventing hypertension pharmaceutical formulation, it is characterised in that by following medicine according to Weight portion is constituted：10 parts of antelope's horn, 80 parts of the shell of seaear, 30 parts of the Radix Astragali, 20 parts of luffa, 25 parts of the red sage root, 15 parts of the fruit of Chinese magnoliavine, pseudo-ginseng 15 parts, 25 parts of Chinese yam, 25 parts of Poria cocos, 20 parts of the fleece-flower root, 20 parts of Radix Angelicae Sinensis, 70 parts of yncaria stem with hooks, 50 parts of chrysanthemum, 70 parts of glutinous rehmannia, the fruit of glossy privet 70 parts, 80 parts of earthworm, 80 parts of radix cyathulae, 50 parts of rhizoma arisaematis, 8 parts of menthol.
5. it is according to claim 1 treatment and preventing hypertension pharmaceutical formulation, it is characterised in that by following medicine according to Weight portion is constituted：2 parts of antelope's horn, 50 parts of the shell of seaear, 20 parts of the Radix Astragali, 10 parts of luffa, 15 parts of the red sage root, 5 parts of the fruit of Chinese magnoliavine, pseudo-ginseng 5 Part, 15 parts of Chinese yam, 15 parts of Poria cocos, 10 parts of the fleece-flower root, 10 parts of Radix Angelicae Sinensis, 30 parts of yncaria stem with hooks, 20 parts of chrysanthemum, 30 parts of glutinous rehmannia, the fruit of glossy privet 30 Part, 50 parts of earthworm, 50 parts of radix cyathulae, 20 parts of rhizoma arisaematis, 2 parts of menthol.
CN201611175978.7A 2016-12-19 2016-12-19 A kind for the treatment of and the pharmaceutical formulation of preventing hypertension Pending CN106728672A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN201611175978.7A CN106728672A (en) 2016-12-19 2016-12-19 A kind for the treatment of and the pharmaceutical formulation of preventing hypertension

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN201611175978.7A CN106728672A (en) 2016-12-19 2016-12-19 A kind for the treatment of and the pharmaceutical formulation of preventing hypertension

Publications (1)

Publication Number Publication Date
CN106728672A true CN106728672A (en) 2017-05-31

Family

ID=58891348

Family Applications (1)

Application Number Title Priority Date Filing Date
CN201611175978.7A Pending CN106728672A (en) 2016-12-19 2016-12-19 A kind for the treatment of and the pharmaceutical formulation of preventing hypertension

Country Status (1)

Country Link
CN (1) CN106728672A (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2022246562A1 (en) * 2021-05-28 2022-12-01 Cohesys Inc. Adhesive devices and uses thereof

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2022246562A1 (en) * 2021-05-28 2022-12-01 Cohesys Inc. Adhesive devices and uses thereof

Similar Documents

Publication Publication Date Title
CN104258310A (en) Traditional Chinese medicine for curing hepatic depression syndrome type melancholia
AU2008281227A1 (en) A pharmaceutical composition for treating diabetes and its process for preparation
CN106728672A (en) A kind for the treatment of and the pharmaceutical formulation of preventing hypertension
CN105456754A (en) Traditional Chinese medicine for treating insomnia and preparation method thereof
CN105497577A (en) Chinese medicinal composition for treating hypertension
Bae et al. Safety of korean herbal medicine used with western medicine on liver function: prospective observational study
CN103768442A (en) Traditional Chinese medicine for treating dizziness due to VBI
CN103417856B (en) Traditional Chinese medicine compound curing hypertension
CN103933280A (en) Traditional Chinese medicine composition for treating PCI (percutanecus coronary intervention) postoperative angina of phlegm-obstructing heart vessel type coronary heart disease and application thereof
CN103989817B (en) A kind of Chinese medicine composition for treating liver-kidney yin deficiency essential hypertension
CN106492117A (en) A kind of Chinese medicine composition for treating diabetes
CN103656179A (en) Traditional Chinese medicine composition for treating phlegmdyspnea
CN101574472B (en) Medicament for treating hyperpiesis and preventing complications
CN104857260A (en) Traditional Chinese medicine preparation for treating encephaledema and preparation method of traditional Chinese medicine preparation
CN104138592A (en) Traditional Chinese medicine for universality anxiety disorder curing
CN103656009B (en) A kind of Chinese medicine composition treating phlegm dyspnea
CN104127834A (en) Formula for treating cough
CN102824532A (en) Traditional Chinese medicine preparation for stomach excessive heat type diabetes mellitus
CN105030985A (en) Traditional Chinese medicine composition with effects of tonifying deficiency and promoting lactation and preparation method of traditional Chinese medicine composition
CN101579514A (en) Traditional Chinese medicine for treating infantile susceptible sweating
CN102961592B (en) Traditional Chinese medicine composition for treating type II diabetes
CN102813806A (en) Traditional Chinese medicine for treating lung heat and body fluid impairment type diabetes
CN107184766A (en) A kind of and spleen and tonifying kidney composition
CN102688367A (en) Medicinal composition for treating hyperuricemia
CN103735718A (en) Composition for treating cold-damp collateral obstruction type systemic scleroderma

Legal Events

Date Code Title Description
PB01 Publication
PB01 Publication
WD01 Invention patent application deemed withdrawn after publication
WD01 Invention patent application deemed withdrawn after publication

Application publication date: 20170531